Chrystal Louis
Hoofd Techniek/Wetenschap/O&O bij TSCAN THERAPEUTICS, INC.
Actieve functies van Chrystal Louis
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TSCAN THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 08-04-2024 | - |
Loopbaan van Chrystal Louis
Eerdere bekende functies van Chrystal Louis
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-11-2022 | 01-03-2024 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Corporate Officer/Principal | 01-07-2020 | 01-11-2022 |
| CELGENE | Corporate Officer/Principal | 01-10-2016 | 01-01-2019 |
Opleiding van Chrystal Louis
| Tulane University School of Public Health & Tropical Medicine | Graduate Degree |
| Tulane University School of Medicine | Doctorate Degree |
| Southwestern University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Beurs
- Insiders
- Chrystal Louis
- Ervaring
